2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve ...
Children with Crohn’s disease are at higher risk of developing perianal fistulas ... These deleterious effects often occur in children and are difficult to treat. Therefore, early treatment or ...
The resulting paper, "Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children ...
The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...
Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in ...
Remestemcel-L is under clinical development by Mesoblast and currently in Phase III for Crohn's Disease (Regional Enteritis).
MetroCreative Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according ...
Infliximab biosimilar is under clinical development by Celltrion and currently in Phase II for Coronavirus Disease 2019 (COVID-19).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback